Clinical evidence-based research on Shenqifuzheng injection with chemotherapy in treatment of advanced gastric carcinoma
Chen Weifeng,Liu Hailin,He Yonghong,Li Zhongcheng
DOI: https://doi.org/10.3969/j.issn.1008-8849.2012.36.002
2012-01-01
Abstract:Objective It is to evaluate the efficacy and safety of Shenqifuzheng injection with chemotherapy in treatment of advanced gastric carcinoma.Methods Literatures were retrieved from Medline,EMBASE,Cochrane Library,CBM,VIP,CNKI databases by computer and from relevant Chinese medical journals by hand.Trial selection,quality evaluation and information extraction were performed according to including and excluding criteria.Meta-analysis was conducted using RevMan 5.0 software.Results Total 16 trials including 1 421 patients were included in the meta-analysis,760 cases in treatment group,661 cases in control group.The results showed the clinical effect(OR=1.86,95%CI(2.36,2.55),Z=3.86,P<0.01),symptom effect(OR=5.05,95%CI(3.08,8.29),Z=6.41,P<0.01),life quality(OR=2.99,95%CI(2.31,3.87),Z=8.35,P<0.01) and immune function such as CD3+(SMD=3.40,95%CI(2.22,4.58),Z=5.63,P<0.01),CD4+(SMD=6.07,95%CI(5.31,6.83),Z=15.69,P<0.01),CD4+/CD8+(SMD=0.38,95%CI(0.34,0.42),P<0.01) of Shenqifuzheng injection group were superior to control group.Besides,Shenqifuzheng injection decreased bone marrow suppression(χ2=5.072,P=0.024),neurotoxicity(χ2=4.593,P=0.032),liver damage(χ2=2.247,P=0.134) caused chemotherapeutics.There were several patients with fever in the course of treatment.Conclusion Shenqifuzheng injection with chemotherapy can increased curative effect,relieve symptom,improve immunological function and life quality,decrease bone marrow suppression.The conclusion need precaution for literature quality.